Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -34.36% is 38% above its 2-year average of -55.14%, near the high end of its 2-year range (-81.23%–-32.49%).
39.57% above its 12-month average of -56.86%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -4.57%.
RETURN ON ASSETS (ROA)
-34.36%
RETURN ON ASSETS (ROA) AVG TTM
-56.86%
RETURN ON ASSETS (ROA) AVG 3Y
N/A
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.57%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.88%
median of 840 covered companies
CURRENT VS SECTOR MEDIAN
-7.80%
vs the sector median at left
Heartflow, Inc. Common Stock
Market Cap
$4.42B
Return on Assets (ROA)
-34.36%
TTM Avg
-56.86%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.40B
Return on Assets (ROA)
28.79%
TTM Avg
8.79%
3Y Avg
1.95%
5Y Avg
1.56%
Market Cap
$4.38B
Return on Assets (ROA)
-9.97%
TTM Avg
-20.59%
3Y Avg
-24.65%
5Y Avg
-22.36%
Market Cap
$4.26B
Return on Assets (ROA)
-41.11%
TTM Avg
-28.92%
3Y Avg
-26.43%
5Y Avg
-22.29%
Market Cap
$4.66B
Return on Assets (ROA)
-31.79%
TTM Avg
-38.86%
3Y Avg
-47.00%
5Y Avg
-47.76%
Market Cap
$4.66B
Return on Assets (ROA)
6.20%
TTM Avg
6.10%
3Y Avg
6.22%
5Y Avg
4.90%
Market Cap
$4.68B
Return on Assets (ROA)
2.32%
TTM Avg
-1.14%
3Y Avg
-5.25%
5Y Avg
-6.57%
Market Cap
$4.70B
Return on Assets (ROA)
-2.47%
TTM Avg
-26.65%
3Y Avg
-27.96%
5Y Avg
-27.52%
Market Cap
$4.13B
Return on Assets (ROA)
7.14%
TTM Avg
-3.40%
3Y Avg
-2.46%
5Y Avg
-5.09%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heartflow, Inc. Common Stock (HTFL) | $4.42B | -34.36% | -56.86% | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.40B | 28.79% | 8.79% | 1.95% | 1.56% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.38B | -9.97% | -20.59% | -24.65% | -22.36% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.26B | -41.11% | -28.92% | -26.43% | -22.29% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | -31.79% | -38.86% | -47.00% | -47.76% |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 6.20% | 6.10% | 6.22% | 4.90% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.32% | -1.14% | -5.25% | -6.57% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.70B | -2.47% | -26.65% | -27.96% | -27.52% |
| LivaNova PLC (LIVN)vs › | $4.13B | 7.14% | -3.40% | -2.46% | -5.09% |
| BillionToOne, Inc. (BLLN)vs › | $4.72B | 4.59% | -6.29% | -18.57% | -18.57% |
ROA
-34.4%
ROE
-42.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -32.49% |
| 2024-12-31 | -81.23% |
| 2023-12-31 | -51.69% |
